




GenOMICC explained molecular mechanisms of disease using host genomics,[PMID: 33307546; PMID: 35255492; PMID: 37198478] rapidly pointing to a new treatment: baricitinib. As a direct result, this drug almost immediately included in the RECOVERY trial, and shown to significantly reduce mortality.[PMID: 35908569] 

